Fundings for medical technologies in April 2015 reached $615 million, led by the huge $225 million funding of Intarcia Therapeutics.
Below are the top fundings for the month.
|Intarcia Therapeutics has raised $225 million in a round of funding according to the company||Subcutaneous, osmotic pump for drug delivery in type 2 diabetes|
|Mesoblast has raised $58.5 million in a round of funding by Celgene Corp.||Precursor and stem cells for cell therapy|
|MyoKardia, Inc., has raised $46 million in a round of funding according to a regulatory filing||Genetically based treatments for cardiomyopathies|
|Scanadu has raised $35 million in a Series B round of funding according to press reports||Device that enables patients to scan and upload diagnostic information|
|Neuronetics, Inc., has completed a $34.3 million Series F funding round, according to the company||Transcranial magnetic stimulation for the treatment of depression|
|Lombard Medical, Inc., has raised $26 million in financing from Oxford Finance, LLC||Stent grafts for treatment of abdominal aortic aneurysm|
|EBR Systems, Inc., has raised $20 million in a round of funding according to the company||Wireless cardiac pacing|
For the complete list of medtech fundings in April 2015, see link.
For a historical list of the individual fundings in medtech, by month, since 2009, see link.